Details
Stereochemistry | ACHIRAL |
Molecular Formula | C6H7N3O |
Molecular Weight | 137.1393 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NNC(=O)C1=CC=NC=C1
InChI
InChIKey=QRXWMOHMRWLFEY-UHFFFAOYSA-N
InChI=1S/C6H7N3O/c7-9-6(10)5-1-3-8-4-2-5/h1-4H,7H2,(H,9,10)
Molecular Formula | C6H7N3O |
Molecular Weight | 137.1393 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:08:16 UTC 2023
by
admin
on
Fri Dec 15 15:08:16 UTC 2023
|
Record UNII |
V83O1VOZ8L
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000175483
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
6.2.4 (ETH/ISO)
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
||
|
WHO-ATC |
J04AM01
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
6.2.4
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
||
|
WHO-ATC |
J04AC01
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
||
|
WHO-VATC |
QJ04AC51
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
||
|
WHO-ATC |
J04AM04
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
||
|
WHO-ATC |
J04AM06
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
||
|
WHO-VATC |
QJ04AM01
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
||
|
WHO-ATC |
J04AM05
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
||
|
NCI_THESAURUS |
C280
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
||
|
WHO-ATC |
J04AM03
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
6.2.4 (ETH/ISO/PYR/RIF)
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
6.2.4 (ETH/ISO/RIF)
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
||
|
WHO-VATC |
QJ04AM02
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
||
|
WHO-VATC |
QJ04AM04
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
||
|
LIVERTOX |
NBK548754
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
||
|
WHO-VATC |
QJ04AM03
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
||
|
FDA ORPHAN DRUG |
6585
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
||
|
WHO-ATC |
J04AM08
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
||
|
WHO-VATC |
QJ04AC01
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
||
|
WHO-VATC |
QJ04AM05
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
||
|
WHO-ATC |
J04AM02
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
6.2.4 (ISO/RIF)
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
||
|
WHO-VATC |
QJ04AM06
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
6.2.4 (ISO/PYR/RIF)
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
||
|
WHO-ATC |
J04AC51
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
||
|
WHO-ATC |
J04AM07
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1647
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
PRIMARY | |||
|
V83O1VOZ8L
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
PRIMARY | |||
|
1497
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
PRIMARY | |||
|
6038
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
PRIMARY | RxNorm | ||
|
9659
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
PRIMARY | |||
|
m6502
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
PRIMARY | Merck Index | ||
|
SUB08326MIG
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
PRIMARY | |||
|
Isoniazid
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
PRIMARY | |||
|
CHEMBL64
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
PRIMARY | |||
|
4188
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
PRIMARY | |||
|
54-85-3
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
PRIMARY | |||
|
200-214-6
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
PRIMARY | |||
|
V83O1VOZ8L
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
PRIMARY | |||
|
6030
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
PRIMARY | |||
|
1349706
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
PRIMARY | |||
|
D007538
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
PRIMARY | |||
|
3767
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
PRIMARY | |||
|
DB00951
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
PRIMARY | |||
|
DTXSID8020755
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
PRIMARY | |||
|
ISONIAZID
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
PRIMARY | Description: Colourless crystals or a white, crystalline powder; odourless. Solubility: Soluble in 8 parts of water and in 40 parts of ethanol (~750 g/l) TS; very slightly soluble in ether R. Category: Tuberculostatic. Storage: Isoniazid should be kept in a well-closed container, protected from light. Definition: Isoniazid contains not less than 98.0% and not more than 101.0% of C6H7N3O, calculated with reference to the dried substance. | ||
|
C600
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
PRIMARY | |||
|
100000092732
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
PRIMARY | |||
|
ISONIAZID
Created by
admin on Fri Dec 15 15:08:16 UTC 2023 , Edited by admin on Fri Dec 15 15:08:16 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
MIC value of the in vitro growth of Mycobacterium Tuberculosis (H37RV strain) of the new anti-tuberculosis terpenoid derived agent tested was 0.02?0.04 ug/ml.
|
||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> INDUCER |
|
||
|
METABOLIC ENZYME -> INHIBITOR |
POTENT
|
||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE INACTIVE -> PARENT |
|
||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT | |||
|
METABOLITE TOXIC -> PARENT | |||
|
METABOLITE -> PARENT | |||
|
METABOLITE ACTIVE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |